Dr Lalchandani Labs share news and announcements

BSE: 541299Healthcare ServicesSmall Cap

₹6.96₹0.19 (2.66%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹7.15.

52-week range of traded prices to 23 Oct 2026

₹5.81Low, 9 Oct 2026₹23.69High, 12 Jan 2026

Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.

Market cap: ₹6.01 Cr4,613th largest listed
P/E: 94.7
P/B: 0.4
Dividend yield: Nonein the last 12 months
ROE: 0.5%
Debt to equity: 0.15
Volume, BSE: 44,000

Dr Lalchandani Labs share news and announcements

273 announcements, routine notices left out, newest first. Page 5 of 6.

Jul 2020
- 22 Jul · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 28/07/2020 ,inter alia, to consider and approve DR LALCHANDANI LABS LIMITED .... (opens in a new tab)
- 20 Jul · Announcement Under Regulation 30 (LODR)-Announcement Regarding Approval Of ICMR For Covid-19 RT-PCR Testing.
  We are glad to announce that 'Dr Lalchandani Labs Limited' have successfully obtain the approval from Indian Council of Medical Research [ICMR] for COVID -19 RT-PCR testing. (opens in a new tab)
- 15 Jul · Statement Of Investor Complaints For The Quarter Ended June 2020
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2020
- 29 Jun · Board meeting
  Board Meeting to be held on 30/06/2020 Stands Cancelled. (opens in a new tab)
- 23 Jun · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 30/06/2020 ,inter alia, to consider and approve DR LALCHANDANI LABS LIMITED .... (opens in a new tab)
May 2020
- 11 May · Shareholding for the Period Ended March 31, 2020
  Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click ....
Apr 2020
- 21 Apr
  Certificate Issued In Compliance Of Regulation 40(9) Of The Provision Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015 For The Half Year Ended 31St March, 2020. (opens in a new tab)
- 21 Apr
  Compliances- Compliance Certificate for the period ended March 31, 2020 (opens in a new tab)
- 20 Apr · Statement Of Investor Complaints For The Quarter Ended March 2020
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Mar 2020
- 9 Mar · Management
  We wish to inform BSE that M/s Vikas Bagga & Co. has been appointed as an Internal Auditor of the Company in a meeting held on 09th March 2020. (opens in a new tab)
Jan 2020
- 17 Jan · Statement Of Investor Complaints For The Quarter Ended December 2019
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Dec 2019
- 16 Dec · Submission Of Cashflow Statement
  Submission Of Cashflow Statement for Results for the Half-year ended 30th September 2019. (opens in a new tab)
- 16 Dec · Management
  Mrs.Anchal Gupta has been appointed as a Chief Financial Officer of the Company with effect from 01st November 2019 in their meeting of Board of Directors held on Friday, 01st November .... (opens in a new tab)
Nov 2019
- 11 Nov · Results
  In terms of the provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the Half Year ended on 30th September 2019 and other applicable provisions, .... (opens in a new tab)
- 11 Nov · Board meeting
  Meeting of the Board of Directors of the Company was held on Monday, 11th November 2019 at 04:00 pm at the Registered Office of the Company at M-20, Basement, Greater Kailash-1, New Delhi-110048. .... (opens in a new tab)
- 8 Nov · Commencement Of Operations In Hyderabad And Bangalore.
  Dr Lalchandani Labs Limited would like to inform you all that to meet the growing demand of the market and for serving more people, we have commenced our business operations in more well-known .... (opens in a new tab)
- 1 Nov · Board meeting
  Meeting on 11 Nov 2019: half yearly results
- 1 Nov · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 11/11/2019 ,inter alia, to consider and approve Dr Lalchandani Labs Limited .... (opens in a new tab)
Oct 2019
- 24 Oct
  Certificate Issued In Compliance Of Regulation 40(9) Of The Provision Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015 For The Half Year Ended 30th September 2019. (opens in a new tab)
- 15 Oct · Shareholding for the Period Ended September 30, 2019
  Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click ....
- 14 Oct · Compliance Certificate For The Period Ended 30Th September 2019.
  Compliance Certificate issued in Compliance of Regulation 7(3) of the provision of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 for the half-year ended 30th September 2019. (opens in a new tab)
- 5 Oct · Statement Of Investor Complaints For The Quarter Ended September 2019
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 1 Oct · Intimation For The Regularisation Of Additional Director.
  This is to inform you that Mrs. Manica Gupta, the Additional Director has been regularised to the Non-Executive Director of the Company. (opens in a new tab)
- 1 Oct · Meeting
  Dear Sir/Madam, We hereby submit summary of proceedings of 02nd Annual General Meeting of Dr Lalchandani Labs Limited held on 30th September, 2019 at 3 p.m, at "The Golden Palms .... (opens in a new tab)
Sep 2019
Aug 2019
- 27 Aug · Board meeting
  This is to inform you that the meeting of the Board of Directors of the Company will be held on Wednesday, 04th September 2019 at 4.00 p.m.at Registered Office at M-20, Greater Kailash,Part-1,South .... (opens in a new tab)
- 24 Aug · Management
  Intimation is hereby given that Dr Lalchandani Labs Limited has appointed Mr. Vikram Grover of M/S. Vikram Grover & Company as its Secretarial Auditor and Scrutinizer for Financial Year .... (opens in a new tab)
Jul 2019
- 22 Jul · Announcement Regarding Tie Up With Express Clinic Centres In Delhi/NCR
  This is to bring in the kind attention of all the stakeholders that in an attempt to increase our operational revenue we have entered into an agreement for rendering diagnostic services .... (opens in a new tab)
- 3 Jul · Statement Of Investor Complaints For The Quarter Ended June 2019
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2019
- 26 Jun · Announcement Regarding Tie Up'S With Aastha Hospital & IVF Centre.
  This is to bring in the kind attention of all the stakeholders that in an attempt to increase our operational revenue we have entered into an agreement for rendering diagnostic services .... (opens in a new tab)
May 2019
- 30 May · Results
  In continuation of our Letter dated May 23, 2019, we wish to inform you that the Board of the Company at its meeting held today, inter alia has transacted the following: a) The Board .... (opens in a new tab)
- 29 May · Management
  This is to inform you that Ms. Swati Poddar, an Associate Member of the Institute of Company Secretaries of India holding Membership no-58616, has been appointed as Company Secretary & .... (opens in a new tab)
- 23 May · Board meeting
  Meeting on 30 May 2019: audited results
- 23 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 30/05/2019 ,inter alia, to consider and approve 1. Audited Financial Results .... (opens in a new tab)
Apr 2019
- 27 Apr
  Compliance under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (opens in a new tab)
- 27 Apr
  Compliance under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (opens in a new tab)
- 27 Apr · Board meeting
  Intimation regarding change in designation and change in constitution of Board of Directors of the Company. (opens in a new tab)
- 18 Apr · Shareholding for the Period Ended March 31, 2019
  Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click ....
- 1 Apr · Statement Of Investor Complaints For The Quarter Ended March 2019
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Feb 2019
- 8 Feb · Announcement Regarding Tie Up's With Various Hospitals
  This is to bring in the kind attention of all the stakeholders that in an attempt to increase our operational revenue we have entered MOU's with a few corporates and various health centres .... (opens in a new tab)
Jan 2019
- 4 Jan · Statement Of Investor Complaints For The Quarter Ended December 2018
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Nov 2018

Dr Lalchandani Labs share news and announcements

Jul 2020

Jun 2020

May 2020

Apr 2020

Mar 2020

Jan 2020

Dec 2019

Nov 2019

Oct 2019

Sep 2019

Aug 2019

Jul 2019

Jun 2019

May 2019

Apr 2019

Feb 2019

Jan 2019

Nov 2018